Risk factors for cervicitis among women with bacterial vaginosis

Journal of Infectious Diseases

Volumn 193, Issue 5, 2006, Pages 617-624

  Marrazzo, Jeanne M ^a,d   Wiesenfeld, Harold C ^b   Murray, Pamela J ^c   Busse, Barbara ^c   Meyn, Leslie ^b   Krohn, Marijane ^b   Hillier, Sharon L ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE;

ADULT; AGING; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; EDUCATION; FEMALE; GONORRHEA; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NONHUMAN; ORAL SEXUAL CONTACT; PATHOGENESIS; PRIORITY JOURNAL; RACE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SMOKING; SUPERINFECTION; UTERINE CERVICITIS; UTERUS BLEEDING; VAGINA FLORA; VAGINA SECRETION; VAGINAL LAVAGE; VAGINITIS;

ADOLESCENT; ADULT; AGE FACTORS; CHLAMYDIA TRACHOMATIS; DNA, BACTERIAL; EDUCATIONAL STATUS; FEMALE; HUMANS; HYDROGEN PEROXIDE; LACTOBACILLUS; MIDDLE AGED; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RISK FACTORS; SEXUAL BEHAVIOR; UTERINE CERVICITIS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 33144486287     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500149     Document Type: Article

References (56)

1. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis- the ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1-6.
2. Paavonen J, Critchlow CW, DeRouen T, et al. Etiology of cervical inflammation. Am J Obstet Gynecol 1986; 154:556-64.
3. Nyirjesy P. Nongonococcal and nonchlamydial cervicitis. Curr Infect Dis Rep 2001; 3:540-5.
4. Marrazzo JM, Handsfield HH, Whittington WL. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol 2002; 100:579-84.
5. Willmott FE. Mucopurulent cervicitis: a clinical entity? Genitourin Med 1988; 64:169-71.
6. Peipert JF, Montagno AB, Cooper AS, Sung CJ. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997; 177:1184-7.
7. Keshavarz H, Duffy SW, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B. Risk factors for and relationship between bacterial vaginosis and cervicitis in a high risk population for cervicitis in Southern Iran. Eur J Epidemiol 2001; 17:89-95.
8. Hillier S, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Mardh P-A, et al., eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:563-86.
9. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988; 158:819-28.
10. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-8.
11. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003; 36:663-8.
12. Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 1999; 48:885-92.
13. Sweet RL. Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol 2000; 8:184-90.
14. Korn AP, Bolan G, Padian N, Ohm-Smith M, Schachter J, Landers DV. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995; 85:387-90.
15. Korn AP, Hessol NA, Padian NS, et al. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol 1998; 178:987-90.
16. Wiesenfeld H, Hillier S, Krohn M, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456-63.
17. Gibbs RS. Chorioamnionitis and bacterial vaginosis. Am J Obstet Gynecol 1993; 169:460-2.
18. Graven MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986; 67:229-37.
19. Hillier SL, Krohn MA, Cassen E, Easterling TR, Rabe LK, Eschenbach DA. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis 1995; 20(Suppl 2):S276-8.
20. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996; 175:435-41.
21. Schwebke JR, Weiss HL. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002; 29:59-64.
22. Schwebke JR, Schulien MB, Zajackowski M. Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infect Dis Obstet Gynecol 1995; 3:199-22.
23. Seek K, Samb N, Tempesta S, et al. Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal. Sex Transm Infect 2001; 77:190-3.
24. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001; 33:894-6.
25. Hillier SL, Wiesenfeld HC, Murray P, Busse B, Krohn MA, Marrazzo JM. A trial of intravaginal Lactobacillus crispatus as an adjunct to metronidazole therapy for treatment of bacterial vaginosis [abstract 197]. In: Program and abstracts of the annual meeting and research symposium of the Infectious Disease Society of Obstetrics and Gynecology (Ottawa, Canada). Ottawa, Canada: International Society for Sexually Transmitted Diseases Research, 2002:69.
26. Arnsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
27. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
28. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines 2002. MMWR Recomm Rep 2002; 51(RR-6):32.
29. Cosentino LA, Landers DV, Hillier SL. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens. J Clin Microbiol 2003; 41:3592-6.
30. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993; 16(Suppl 4):S273-81.
31. Holdeman L, Cato EP, Moore WEC. Anaerobe laboratory manual. 4th ed. Blacksburg, VA: Anaerobe Laboratory Virginia Polytechnic Institute and State University, 1977:143-8.
32. 2) production by Lactobacillus species. J Clin Microbiol 2003; 41:3260-4.
33. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173:534-43.
34. Scholes D, Stergachis A, Ichikawa LE, Heidrich FE, Holmes KK, Stamm WE. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol 1998; 91:993-7.
35. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174:1058-63.
36. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 2001; 184:1431-6.
37. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002; 185:1307-13.
38. Yudin MH, Landers DV, Meyn L, Hillier SL. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003; 102:527-34.
39. Tchamouroff SE, Panja SK. The association between receptive cunnilingus and bacterial vaginosis. Sex Transm Infect 2000; 76:144-5.
40. Schwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 1999; 180:1632-6.
41. Brabin L. Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression. AIDS Patient Care STDS 2002; 16:211-21.
42. 2-generating lactobacilli. J Infect Dis 1991; 164:94-100.
43. Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, Spear GT. Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis 2000; 181:1574-80.
44. Valore EV, Park CH, Igreti SL, Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002; 187:561-8.
45. Olmsted SS, Meyn LA, Rohan LC, Hillier SL. Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis 2003; 30:257-61.
46. Eggert-Krause W, Botz I, Pohl S, Rohr G, Strowitzki T. Antimicrobial activity of human cervical mucus. Hum Reprod 2000; 15:778-84.
47. Hein M, Valore EV, Helmig RB, Uldbjerg N, Ganz T. Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 2002; 187:137-44.
48. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000; 183:1243-8.
49. Cohen CR, Plummer FA, Mugo N, et al. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999; 13:327-32.
50. Cauci S, Guaschino S, De Aloysio D, et al. Interrelationships of interleukin-8 with interleukin-1β and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003; 9:53-8.
51. Paavonen J, Roberts PL, Stevens CE, et al. Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin. Am J Obstet Gynecol 1989; 161:128-35.
52. Chandeying V, Sutthijumroon S, Tungphaisal S. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: a response of chlamydia-positive and chlamydia-negative forms. J Med Assoc Thai 1989; 72:331-7.
53. Manhart LE, Critchlow CW, Holmes KK, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187:650-7.
54. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37:319-25.
55. Nugent RP, Hillier SL. Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. The Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Sex Transm Dis 1992; 19:198-202.
56. Peipert JF, Ness RB, Soper DE, Bass D. Association of lower genital tract inflammation with objective evidence of endometritis. Infect Dis Obstet Gynecol 2000; 8:83-7.